Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer

Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer

Which subgroups patients with muscle-invasive bladder cancer (MIBC) could benefit most from adjuvant chemotherapy (ACT) is blurred. Here we tried to stratify MIBC patients with tumor infiltrating mast cells (TIMs), explore the prognostic and predictive value of TIMs, and provide possible cellular ex...

Full description

Bibliographic Details
Main Authors: Zheng Liu, Yu Zhu, Le Xu, Junyu Zhang, Huyang Xie, Hangcheng Fu, Quan Zhou, Yuan Chang, Bo Dai, Jiejie Xu
Format: Article
Language:English
Published: Taylor & Francis Group 2018-09-01
Series:OncoImmunology
Subjects:
adjuvant chemotherapy
bladder cancer
mast cells
overall survival
prognosis
recurrence-free survival
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1474317

Internet

http://dx.doi.org/10.1080/2162402X.2018.1474317

Similar Items